View Post

Pediatric Influenza Cases Increased Last Week

In COVID-19, Latest News by Precision Vaccinations

The US Centers for Disease Control and Prevention (CDC) reported today, the 2020-2021 influenza season has begun to accelerate in the pediatric population.
The CDC confirmed on May 14, 2021, the percentages of provider visits in Week #18 continued to increase for one age group (0–4 years) and remained stable for the remaining age groups compared with Week #17. 
About 6% of provider visits for children were related to the seasonal flu.

View Post

Immunocompromised Pediatric Patients Showed T-cell Activity and Humoral Immunity Against SARS-CoV-2

In COVID-19, Latest News by Precision Vaccinations

According to data from a recent study of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins.
The new study published on May 13, 2021, led by researchers at Children’s National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.

View Post

Universal Cancer Vaccine Candidate Presents Positive Long-term Benefits

In COVID-19, Latest News by Precision Vaccinations

A clinical-stage leader in immune-stimulatory vaccines for cancer announced the publication of its favorable long-term Overall Survival (OS) data from a Phase I trial evaluating a universal cancer vaccine candidate, UV1, in combination with checkpoint inhibitor ipilimumab, in patients with metastatic malignant melanoma.
UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. 

View Post

Tuberculosis Vaccine Recommendations Launch Update Process

In COVID-19, Latest News by Precision Vaccinations

The World Health Organization (WHO) announced it is convening a Guideline Development Group to advise on updates to its recommendations on managing tuberculosis (TB) in children and adolescents.
Despite significant progress and greater understanding of the challenges faced in addressing TB in children and adolescents, critical gaps remain in TB case detection and provision of TB preventive treatments, stated the WHO on May 7, 2021.
The first edition of Guidance for national tuberculosis programs on the management of tuberculosis in children was published in 2006. 

View Post

COVID-19 Vaccines Potentially Authorized for Children

In COVID-19, Latest News by Precision Vaccinations

The US Food and Drug Administration (FDA) announced today it had scheduled a meeting of the Center for Biologics Evaluation and Research (CBER) to convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC).
During this meeting on June 10, 2021, the FDA will provide a status update on its approach to Emergency Use Authorization (EUA) for COVID-19 vaccines intended for use in individuals 12 through 17 years of age. 

View Post

US Funds $250 Million to Create New Vaccination Workforce

In COVID-19, Latest News by Precision Vaccinations

The U.S. Department of Health and Human Services (HHS) recently announced the availability of approximately $250 million to develop and support a community-based vaccination workforce.
Announced on May 4, 2021, this new workforce will serve as trusted voices sharing information about vaccines, increase COVID-19 vaccine confidence, and address any barriers to vaccination for individuals living in vulnerable and medically underserved communities.

View Post

US Government Orders Additional Smallpox-Monkeypox Vaccines

In COVID-19, Latest News by Precision Vaccinations

The U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised the final $12 million option for JYNNEOS, an innovative combination of Smallpox and Monkeypox vaccine.
JYNNEOS is the only U.S. Food and Drug Administration-approved non-replicating smallpox and monkeypox vaccine for preventing disease in adults 18 years of age and older.

View Post

Can mRNA Vaccines Defeat Herpes?

In COVID-19, Latest News by Precision Vaccinations

A research team at the University of Pennsylvania (UPenn) has been working on preventing and treating genital herpes (HSV-2) for years and recently found success with an mRNA vaccine approach, even before the COVID-19 pandemic.
The goals of a HSV-2 vaccine are to keep the herpes virus dormant. Or if the virus escapes, prevent it from causing symptoms. 
Professor Harvey M. Friedman demonstrated success in animal models in July 2020. This study found not only targeting entry molecules, but also targeting the HS-2 ability to evade the immune system.

View Post

College Men Need HPV Vaccination Too

In COVID-19, Latest News by Precision Vaccinations

Using data from the 2010-2018 National Health Interview Surveys, Michigan Medicine researchers found college-age men significantly trailed women’s human papillomavirus (HPV) vaccination rates.
This study found just 16% of men who were 18 to 21 years old had received at least one dose of the HPV vaccine.
In comparison, 42% of women in the same age bracket had gotten at least one dose of the HPV vaccine.

View Post

Earn $100 For Your COVID-19 Vaccination

In COVID-19, Latest News by Precision Vaccinations

The governor of West Virginia announced the state is offering a $100 savings bond to each person from 16 to 35 years old who chooses to receive a COVID-19 vaccine.
Furthermore, Governor Jim Justice confirmed that this incentive is retroactive on April 26, 2021, meaning all eligible West Virginians who have already been vaccinated will also receive a $100 savings bond.
“We have vetted this in every way that we possibly can to be assured that we can use our CARES dollars to do exactly just this,” Gov. Justice said in a press release.